AzTrials
AzTrials

Multiple SclerosisNCT02301442

Step it Up: An Exercise and Behaviour Change Programme for People With Multiple Sclerosis

A study testing Exercise + behaviour change intervention in people with Multiple Sclerosis, run by University of Limerick at 1 site in Ireland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Exercise has consistently yielded short-term, positive effects on health outcomes in people with multiple sclerosis (MS). However, these effects have not been maintained in the long-term. Behaviour change interventions aim to promote long-term positive lifestyle change. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Multiple Sclerosis
What is being tested?
Exercise + behaviour change intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
65 participants
Where
1 siteIreland
Study dates
Sep 2014to Feb 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Physician-confirmed formal diagnosis of MS
  • Patient Determined Disease Steps score of 0-3
  • A sedentary lifestyle (< 30 minutes of moderate to strenuous exercise one day or more per week over the last six months)
  • Willing to give written informed consent.

Who cannot join

  • Pregnancy
  • MS relapse in the last 12 weeks
  • Changes to MS medication or steroid treatment in the last 12 weeks.

Trial locations and contacts

1 site in 1 country.

Ireland1 site
  • Department of Clinical Therapies, University of Limerick

    Limerick, Munster

Other trials in Ireland

About this study

Official title: A Randomised Controlled Trial of an Exercise Plus Behaviour Change Intervention in People With MS: the "Step it Up" Study Protocol

Exercise has consistently yielded short-term, positive effects on health outcomes in people with multiple sclerosis (MS). However, these effects have not been maintained in the long-term. Behaviour change interventions aim to promote long-term positive lifestyle change. This study, namely, "Step it Up" will compare the effectiveness of an exercise plus Social Cognitive Theory (SCT)-based behaviour change intervention with an exercise plus control education intervention on walking mobility among people with MS.

Read the detailed description
  1. Background and study aims Exercise has consistently yielded short-term, positive effects on health outcomes in people with multiple sclerosis (MS). However, these effects have not been maintained in the long-term. Behaviour change interventions aim to promote long-term positive lifestyle change. This study, namely, "Step it Up" will compare the effect of an exercise plus Social Cognitive Theory (SCT)-based behaviour change intervention with an exercise plus control education intervention on walking mobility among people with MS. Our hypothesis is that those in the exercise and SCT-based intervention will achieve significantly more improvement in walking mobility than the control group post-intervention (12 weeks) and that this improvement will be maintained at 24- and 36- week follow up.
  2. What does the study involve? Exercise plus contact control education intervention The control group will receive an exercise and a didactic control education component. The exercise intervention will include aerobic and strengthening components and will be delivered by physiotherapists. The aim of the exercise component is to progressively increase the intensity of both aerobic and strengthening activities to enable the participants to reach the recently published MS exercise guidelines (Latimer- Cheung et al 2013). The aerobic activity will be walking, the intensity of which will be monitored using step rate measured using the Yamax digiwalker pedometer* (which will be provided to all participants) and an exercise log to document duration of walking exercise and number of steps taken. It is widely accepted that 100 steps per minute equates to three MET or moderate intensity physically active (PA) among people with MS (Agiovlasitis and Motl 2014). Participants will begin with 10 minutes of walking twice weekly at a rate of 100 steps/minute and increase incrementally in 5 minute intervals over 5 weeks until they reach the guideline of 30 minutes twice weekly (Latimer-Cheung et al 2013).

The strengthening programme is based on a community-based exercise programme that has been evaluated previously (Garrett et al 2013) and will consist of 10 exercises targeting major muscle groups for the upper and lower extremities using elastic resistance band. Participants will begin with one set of 10-15 repetitions and gradually increase the number of sets, repetitions and level of resistance until they meet the target of two sets of each exercise twice weekly with sufficient resistance that they are failing on the 12th repetition. Over the 10-week programme participants will attend the group exercise class on six occasions, supplemented with a telephone coaching call in the weeks without classes (intervention weeks 4, 6, 7 and 9). These telephone calls will consist of direct questions about the frequency, intensity, type and duration of exercise they have completed and whether they have experienced any adverse events or relapses. After each of the group exercise classes the control group will receive an education session about topics unrelated to physical activity behaviour, e.g. diet, vitamin D, sleep, temperature and hydration, and immunisations and vaccinations.

Exercise plus SCT-based intervention The exercise plus SCT-based intervention group will receive the same exercise intervention as the control group (as described in the previous section).This group will also receive a behaviour change intervention based on the principles of SCT. The SCT-based education sessions will be delivered after each exercise session by physiotherapists and will incorporate the principle elements of SCT including self-efficacy, outcome expectations, impediments and goal-setting. Beyond providing presentation notes, individual reflection and written exercises, group discussion on each of the principles of SCT, and providing on-going feedback on all aspects of PA behaviour, the program will include video files of people with MS discussing PA behaviour and their experiences of initiating and maintaining a physically-active lifestyle. On the weeks when the participants do not attend group sessions, they will receive a telephone coaching call from the physiotherapist. These coaching calls will consist of guided conversations that consider the components of SCT delivered in the previous session and a revision of other components.

  1. What are the possible benefits and risks of participating? Benefits to the participants include access to a free physiotherapy-led exercise programme, of which benefits such as improved aerobic capacity, mobility, fatigue, mood, muscle strength are anticipated. The education session may also help participants to keep those benefits for longer. The investigators do not envisage any adverse effects of these interventions.
  2. Where is the study run from? This study has been organised by Clinical Therapies, University of Limerick.
  3. When is study starting and how long is it expected to run for? This study started in September 2014 and it is anticipated that data collection will end in March 2016. Participants will be recruited until June 2015.
  4. Who is funding the study? The Irish Health Research Board, Health Research Award Grant is funding the study.
  5. Who is the main contact? Dr. Susan Coote (susan.coote@ul.ie)
Being tested
Exercise + behaviour change intervention, Exercise + control education
Medical subject headings
Multiple Sclerosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise + behaviour change interventionBehavioural

    In addition to the same exercise intervention as the control group, this group will receive a behaviour change intervention. This will be delivered after each exercise session and will incorporate the elements: self-efficacy, outcome expectations, impediments and goal-setting. On the weeks when the participants do not attend group sessions, they will receive telephone calls from physiotherapists. This will consist of guided conversations that consider content delivered in previous sessions.

  • Exercise + control educationBehavioural

    The control group will receive exercise and education components. The exercise intervention includes aerobic \& strengthening components and are in line with MS exercise guidelines (Latimer-Cheung et al 2013). The aerobic activity is walking, measured using pedometers \& exercise logs. The strengthening programme consists of 10 exercises targeting major muscle groups for the upper and lower extremities using elastic resistance band. Over the 10-week programme participants will attend 6 group exercise class, supplemented with telephone calls in the weeks without classes. After each group exercise class this group will receive an education session about the following: diet, vitamin D, sleep, temperature and hydration, and immunisations and vaccinations.

Study groups in NCT02301442
Study groupRoleWhat they receive
Exercise + behaviour change interventionExperimentalThis arm of the trial includes assessments at weeks 0, 12, 24 and 36. A 10-week exercise + behaviour change intervention will be delivered by physiotherapists between weeks 1 and 11.
Receives: Behavioral: Exercise + behaviour change intervention
Exercise + control educationActive comparatorThis arm of the trial includes assessments at weeks 0, 12, 24 and 36. A 10-week exercise + control education intervention will be delivered by physiotherapists between weeks 1 and 11.
Receives: Behavioral: Exercise + control education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in walking mobility from weeks 1 to 36

    Change in walking mobility will be measured using the Timed up and Go test, the Six Minute Walk Test and the Multiple Sclerosis Walking Scale-12. These measures will be completed at weeks 1, 12, 24 and 36. The primary outcome will be the change over time from week 1 to week 36.

    Measured: Weeks 1 to 36

Secondary outcomes (7)
  1. Change in lower limb functional muscle strength from weeks 1 to 36

    Change in lower limb muscle strength will be measured using the 5 times sit to stand test. This measure will be completed at weeks 1, 12, 24 and 36.

    Measured: Weeks 1 to 36

  2. Change in aerobic fitness from weeks 1 to 36

    Change in aerobic fitness will be measured using the Modified Canadian Aerobic Fitness Test. This measure will be completed at weeks 1, 12, 24 and 36.

    Measured: Weeks 1 to 36

  3. Change in anxiety and depression from weeks 1 to 36

    Change in anxiety and depression will be measured using the Hospital Anxiety and Depression Scale. This measure will be completed at weeks 1, 12, 24 and 36.

    Measured: Weeks 1 to 36

  4. Change in cognitive processing from weeks 1 to 36

    Change in cognitive processing will be measured using the Symbol Digit Modalities Test. This measure will be completed at weeks 1, 12, 24 and 36.

    Measured: Weeks 1 to 36

  5. Change in physical activity levels from weeks 1 to 36

    Change in phyiscal activity levels will be measured using the Godin Leisure-Time Exercise Questionnaire, the International Physical Activity Questionnaire and an objective measure of physical activity- the SenseWear Arm band accelerometer. These measures will be completed at weeks 1, 12, 24 and 36.

    Measured: Weeks 1 to 36

  6. Change in self-reported fatigue from weeks 1 to 36

    Change in self-reported fatigue will be measured using the Modified Fatigue Impact Scale. This measure will be completed at weeks 1, 12, 24 and 36.

    Measured: Weeks 1 to 36

  7. Change in self-reported impact of MS from weeks 1 to 36

    Change in self-reported impact of MS will be measured using the Multiple Sclerosis Impact Scale-29. This measure will be completed at weeks 1, 12, 24 and 36.

    Measured: Weeks 1 to 36

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2014 (estimated)
  2. Study startSep 2014
  3. Primary completionFeb 2016
  4. Study completionFeb 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
65 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02301442
Sponsor's protocol ID
ULimerick
Status last verified
May 2016
First submitted
13 Nov 2014
Last updated
13 May 2016
Results posted
No
Data monitoring committee
No

Publications

  • Hayes S, Uszynski MK, Motl RW, Gallagher S, Larkin A, Newell J, Scarrott C, Coote S. Randomised controlled pilot trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the Step it Up study. BMJ Open. 2017 Oct 12;7(10):e016336. doi: 10.1136/bmjopen-2017-016336.

    PubMed 29025830
  • Coote S, Uszynski M, Herring MP, Hayes S, Scarrott C, Newell J, Gallagher S, Larkin A, Motl RW. Effect of exercising at minimum recommendations of the multiple sclerosis exercise guideline combined with structured education or attention control education - secondary results of the step it up randomised controlled trial. BMC Neurol. 2017 Jun 24;17(1):119. doi: 10.1186/s12883-017-0898-y.

    PubMed 28646860
  • Coote S, Gallagher S, Msetfi R, Larkin A, Newell J, Motl RW, Hayes S. A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol. BMC Neurol. 2014 Dec 21;14:241. doi: 10.1186/s12883-014-0241-9.

    PubMed 25528262

Questions about this trial

What is this clinical trial studying?

A study testing Exercise + behaviour change intervention in people with Multiple Sclerosis, run by University of Limerick at 1 site in Ireland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 May 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in walking mobility from weeks 1 to 36 (time frame: Weeks 1 to 36). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02301442, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2016; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in